You found a clinic. It is near Mid Rivers Mall Drive, a short hop off I-70, and the website uses all the right words: "FDA-approved," "clinically proven," "breakthrough." Your partner has been struggling for a long time, and you want this to be the one. Before you hand over an insurance card or a credit card, it is worth ten minutes to check whether those words mean what they seem to.
This is a local guide for partners in St. Peters and nearby St. Charles County who are helping someone they love evaluate depression care.
Why the FDA wording matters to you
It matters to most people. Of the 443 Midwest adults in the survey we commissioned, 59 percent expect FDA approval to be big or decisive if a new depression treatment is offered. When ranking provider priorities, 27 percent placed FDA-approved treatment in their top two. The figures are final and validated. St. Peters belongs to the St. Louis TV market, and its 31 respondents, a small group, rated approval big or decisive at 58 percent.
Clinics know this, which is why "FDA-approved" appears in marketing even when it only partly applies. The good news is that the claims are checkable.
Step 1: Learn the four categories
Nearly every depression treatment you will see advertised falls into one of these:
- FDA-approved for depression. In the ketamine family, that is only esketamine, sold as Spravato, a nasal spray used when depression has shrugged off other care. A certified clinic gives each dose and keeps the patient under observation for two hours at minimum. Here is a Brain Recovery Centers explainer on Spravato.
- FDA-cleared. The term for devices. TMS, which relies on magnetic pulses and no drugs, holds clearance for depression that antidepressants did not resolve.
- Off-label. An approved drug used for another purpose. IV ketamine for depression is an example: ketamine is approved as an anesthetic.
- Not FDA-approved. Includes compounded at-home ketamine products, which the FDA has cautioned against using without anyone monitoring.
When a website says "FDA-approved," your job is to figure out which of these four the treatment actually is.
Step 2: Read the website closely
Watch for phrases that sound like approval but are not:
- "Uses an FDA-approved medication." That may be true of IV ketamine, which is approved as an anesthetic. It does not mean approved for depression.
- "FDA-registered facility" or "FDA-registered pharmacy." Registration is not approval of a treatment.
- "Clinically proven" or "backed by research." These are not regulatory terms.
- Figures for how often it works, presented as promises. Legitimate clinics describe results cautiously.
If the site names Spravato specifically, the clinic should be certified to give it. If it names only "ketamine," ask which kind.
Step 3: Verify certification
For esketamine, you can check the manufacturer's treatment center search, which lists certified locations. If a clinic says it offers Spravato but does not appear there, ask them about it directly. For TMS, ask which device they use and whether a psychiatrist supervises treatment.
Step 4: Call and ask four plain questions
- "Is the treatment you're recommending FDA-approved or cleared for depression, or is it an off-label use?"
- "Is a psychiatrist or physician involved in evaluating my partner before treatment?"
- "Will you check our insurance and handle prior authorization?"
- "What will we owe for the first month, in writing?"
A trustworthy clinic answers these without hedging. If you hear "it's basically the same thing" when you ask about approval, that is your answer.
Step 5: Bring it back to your partner's doctor
Even the best website cannot tell you whether a treatment fits your partner. Their own doctor can. The single most persuasive voice in our survey was the respondent's own doctor, chosen by 74 percent. Most would start there too: a primary care visit is the first stop for 56 percent. A search engine was the starting point for just 12 percent.
That is a useful reminder for the partner doing the research. Your search is valuable preparation. It is not the final word.
Step 6: Think through the St. Peters logistics
Where a clinic sits matters more than it might seem. With esketamine, your partner stays out of the driver's seat until the next day and a night of sleep, and early treatment usually means two visits a week, each with a two-hour observation period. If you work across the river in St. Louis County, a clinic near home in St. Peters may be easier than one near your office, or the reverse. Plan who drives before the first appointment.
With TMS, your partner can typically drive themselves, but the course often means a session every weekday for four to six weeks, so a clinic close to home or work matters a great deal.
Step 7: Check the insurance claim too
A clinic that says "we take insurance" may mean it takes some plans, for some services. Phone the member line printed on your partner's insurance card and ask whether this specific clinic is in network for this specific treatment. Then ask whether prior authorization is required. Those two answers will tell you more than any page on the clinic's website.
A note on privacy
Some partners worry about being seen walking into a mental health clinic in a community where everyone knows everyone. In our survey, 11 percent put a private or discreet provider in their top two priorities. It is fair to ask a clinic about its entrance, waiting area, and how it handles appointment reminders.
Why this is worth the effort
Most people do not even know the name of the one FDA-approved option in the ketamine family. Spravato was a completely unfamiliar name to 73 percent of the people we asked. That unfamiliarity makes it easy for loose marketing language to fill the gap. Ten minutes of checking protects your partner, your budget, and your trust in whatever comes next.
None of this is medical advice. The question of whether a treatment suits your partner is theirs to settle with a clinician who has their full records.
If your partner is thinking about suicide or you believe they are in danger, call or text 988 now. Trained Suicide and Crisis Lifeline staff answer through the night and the weekend, for them and for you.
Methodology
Results are from a Pollfish consumer panel survey that our publisher commissioned and funded. It closed June 23, 2026; by then 443 adults between 18 and 64 had completed it in Missouri, Illinois, Indiana, Minnesota, Wisconsin, Oklahoma, Ohio, Iowa, Kansas, and Nebraska. The panel's validation is complete.